Article Versions Notes

Rivero-Juarez A, Vallejo N, Lopez-Lopez P, Díaz-Mareque AI, Frias M, Vallejo A, Caballero-Gómez J, Rodríguez-Velasco M, Molina E, Aguilera A. Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients. Microorganisms. 2020; 8(1):51. https://doi.org/10.3390/microorganisms8010051

Rivero-Juarez, Antonio, Nicolau Vallejo, Pedro Lopez-Lopez, Ana Isabel Díaz-Mareque, Mario Frias, Aldara Vallejo, Javier Caballero-Gómez, María Rodríguez-Velasco, Esther Molina, and Antonio Aguilera. 2020. "Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients" Microorganisms 8, no. 1: 51. https://doi.org/10.3390/microorganisms8010051

Rivero-Juarez, A., Vallejo, N., Lopez-Lopez, P., Díaz-Mareque, A. I., Frias, M., Vallejo, A., Caballero-Gómez, J., Rodríguez-Velasco, M., Molina, E., & Aguilera, A. (2020). Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients. Microorganisms, 8(1), 51. https://doi.org/10.3390/microorganisms8010051